LXEO - Lexeo Therapeutics, Inc.

QQQ $ 468.28 $ 9.96 (2.17 %)

DIA $ 409.73 $ 1.01 (0.25 %)

SPY $ 554.79 $ 5.63 (1.03 %)

TLT $ 100.61 $ -0.08 (-0.08 %)

GLD $ 232.25 $ -0.37 (-0.16 %)

Previous Close

$ 10.24

Open

Bid

$ 10.23 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 9.00 - $ 22.33

Volume

112,497

Average Volume

Market Cap

338.54M

Beta (5Y Monthly)

$ 2.07

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-11-2024	12-31-2023	10-K
4	12-11-2023	09-30-2023	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Chardan Capital Maintains Buy on Lexeo The...
08/14/2024 10:40:53

Chardan Capital analyst Geulah Livshits maintains Lexeo Therapeutics (NASDAQ:LXEO) with a Buy and maintains $23 price target.

HC Wainwright & Co. Maintains Buy on Lexeo...
08/13/2024 18:22:47

HC Wainwright & Co. analyst Mitchell Kapoor maintains Lexeo Therapeutics (NASDAQ:LXEO) with a Buy and lowers the price t...

RBC Capital Reiterates Outperform on Lexeo...
08/13/2024 16:44:27

RBC Capital analyst Luca Issi reiterates Lexeo Therapeutics (NASDAQ:LXEO) with a Outperform and maintains $24 price target.

Lexeo Therapeutics Q2 2024 GAAP EPS $(0.64...
08/12/2024 11:22:59

HC Wainwright & Co. Reiterates Buy on Lexe...
07/16/2024 12:08:12

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Lexeo Therapeutics (NASDAQ:LXEO) with a Buy and maintains $22 pri...

Chardan Capital Maintains Buy on Lexeo The...
07/16/2024 02:46:40

Chardan Capital analyst Geulah Livshits maintains Lexeo Therapeutics (NASDAQ:LXEO) with a Buy and maintains $23 price target.

Crude Oil Moves Lower; Goldman Sachs Posts...
07/15/2024 18:32:44

why-solaredge-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-mondays-mid-day-session

Why SolarEdge Shares Are Trading Lower By ...
07/15/2024 17:23:20

nasdaq-surges-over-1-lexeo-therapeutics-shares-plummet

Nasdaq Surges Over 1%; Lexeo Therapeutics ...
07/15/2024 16:05:30

dow-jumps-over-200-points-ny-empire-state-manufacturing-index-falls-in-july

Dow Jumps Over 200 Points; NY Empire State...
07/15/2024 13:47:57

Lexeo Therapeutics Report Interim Data Of ...
07/15/2024 10:07:43

Across both the Lexeo SUNRISE-FA Phase 1/2 clinical trial and the Weill Cornell Medicine investigator-initiated Phase 1A trial,...

Lexeo Therapeutics To Host Investor Webcas...
07/11/2024 12:21:11

Lexeo Therapeutics, Inc. (NASDAQ:LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for geneti...

Baird Initiates Coverage On Lexeo Therapeu...
06/13/2024 09:15:08

Baird analyst Brian Skorney initiates coverage on Lexeo Therapeutics (NASDAQ:LXEO) with a Outperform rating and announces Pr...

HC Wainwright & Co. Initiates Coverage On ...
06/06/2024 10:41:43

HC Wainwright & Co. analyst Mitchell Kapoor initiates coverage on Lexeo Therapeutics (NASDAQ:LXEO) with a Buy rating and...

matterport-sea-limited-ingevity-and-other-big-stocks-moving-higher-on-monday

Matterport, Sea Limited, Ingevity And Othe...
04/22/2024 14:10:39

Lexeo Therapeutics Announces In-License Ag...
04/22/2024 11:32:21

Lexeo Therapeutics shares are trading high...
04/16/2024 11:37:09

Lexeo Therapeutics Granted FDA Fast Track ...
04/16/2024 11:31:58

RBC Capital Maintains Outperform Rating fo...
03/12/2024 17:00:15

RBC Capital Maintains Outperform on Lexeo ...
03/12/2024 15:29:52

RBC Capital analyst Luca Issi maintains Lexeo Therapeutics (NASDAQ:LXEO) with a Outperform and raises the price target from ...